Isolation and characterization of a new antibiotic, malolactomycin A. 1993

K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D018942 Macrolides A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties. Macrolide

Related Publications

K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
August 1971, The Journal of antibiotics,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
March 1966, The Journal of antibiotics,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
July 1970, The Journal of antibiotics,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
January 1963, Antimicrobial agents and chemotherapy,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
November 1964, The Journal of antibiotics,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
January 1964, Antimicrobial agents and chemotherapy,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
August 1980, The Journal of antibiotics,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
March 1969, The Journal of antibiotics,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
March 1976, The Journal of antibiotics,
K Kobinata, and H Koshino, and H Kusakabe, and Y Kobayashi, and I Yamaguchi, and K Isono, and H Osada
April 1972, The Journal of antibiotics,
Copied contents to your clipboard!